Smart Insulin Pens is an electronic medical records device that reminds patient to take your medicine or tracks how much medicine patient taken.
The global smart insulin pens market is dominated by few players from Europe and North America, key players include Emperra, Patients Pending, Roche, Diamesco, Companion Medical and Common Sensing, global top two players hold a share over 50%.

Market Analysis and Insights: Global Smart Insulin Pens Market
In 2020, the global Smart Insulin Pens market size was US$ 11 million and it is expected to reach US$ 20 million by the end of 2027, with a CAGR of 8.6% between 2021 and 2027
Global Smart Insulin Pens Scope and Market Size
The global Smart Insulin Pens market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Smart Insulin Pens market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Smart Insulin Pens
Smart Pen Caps

Segment by Application
Home Care Settings
Hospitals & Clinics
Others

By Company
Emperra
Roche
Diamesco
Companion Medical
Patients Pending
Common Sensing
Jiangsu Delfu
Dnurse

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE